Phenotypeca secures commercial contract with Isogenica
March 2022
Phenotypeca has won a significant commercial contract with Isogenica. Isogenica - specialists in single-domain biotherapeutics - will be using Phenotypeca’s innovative platform to optimise high-level secretion of correctly folded VHHs and deploy yeast-display for VHHs to accelerate drug candidate selection. The contract, which begins in April, will span a period of nine months.
The project builds on a growing strategic relationship with Isogenica.
Navigation
Office Address
Phenotypeca Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF.
Email: info@phenotypeca.com
Research Address
University of Nottingham's Synthetic Biology Research Centre in the Biodiscovery Institute, University of Nottingham, University Boulevard, Nottingham, United Kingdom, NG7 2RD
© Copyright 2022 Phenotypeca Ltd. All Rights Reserved. Phenotypeca Ltd is a limited company incorporated in England with registered number 11700555.
Terms and Conditions | Privacy Policy
Website built by IvyJack Communications Ltd